Journals / İstanbul Kuzey Klinikleri / 2021 / Cilt: 8 - Sayı: 3

Assessment of respiratory tract viruses in febrile neutropenic etiology in children and comparison with healthy children with upper/lower respiratory tract infection

Pages
249–254
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION: Our study results show that viral agents play an important role in the etiology of FN.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: This study aims to compare the frequency of respiratory viruses using real-time and multiplex polymerase chain reaction technology and nasopharyngeal swabs taken during exacerbation of patients aged 0–18 years followed for febrile neutropenia (FN) with non-FN children.
📊
Key Findings & Data:METHODS: This prospective study included a total of 40 patients with FN and malignancies followed at Eskisehir Osmangazi University, Department of Pediatric Hematology and Oncology.
💡
Conclusion & Impact:CONCLUSION: Our study results show that viral agents play an important role in the etiology of FN.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: This study aims to compare the frequency of respiratory viruses using real-time and multiplex polymerase chain reaction technology and nasopharyngeal swabs taken during exacerbation of patients aged 0–18 years followed for febrile neutropenia (FN) with non-FN children. METHODS: This prospective study included a total of 40 patients with FN and malignancies followed at Eskisehir Osmangazi University, Department of Pediatric Hematology and Oncology. The control group (n=76) consisted of age-matched patients with upper respiratory tract infections (URTIs) or lower respiratory tract infections (LRTIs) who were admitted to the emergency service due to fever. RESULTS: Viral agents were detected in 16 of 53 FN attacks (30.1%). The most commonly isolated viruses were coronavirus (23.7%, n=9), influenza B (18.4%, n=7), and adenovirus (18.4%, n=7). Of 76 children diagnosed with URTI with fever (52.6%) had viral agents, and only 28 of them had a single agent. The most commonly isolated virus was adenovirus (28.6%, n=14). Viral factors were found in 32 of 42 patients (76.1%) patients diagnosed with LRTI, while respiratory syncytial virus was the most common virus in 27 patients (21.7%, n=5). CONCLUSION: Our study results show that viral agents play an important role in the etiology of FN. This is the first study to show that viral agents play an important role in the etiology of this disease and viral factors in non-neutropenic febrile children at the same time period by detecting respiratory viruses in 30% of FN cases. More similar studies provide antiviral therapy in selected patients, as well as these studies lead to reduce the use of antimicrobial agents or allow more selective use of antibiotics and/or the earlier discontinuation of these antibiotics in febrile neutropenic children who have been shown to have viral cause of respiratory tract infection based on clinical and microbiological/molecular diagnostic criteria.

🔖

Cite This Article

Dinleyici, E. C., Bor, O., Turhan, A. B., Ozdemir, Z. C., Kasifoglu, N., Us, T., Yildirim, G. K. (2022). Assessment of respiratory tract viruses in febrile neutropenic etiology in children and comparison with healthy children with upper/lower respiratory tract infection. İstanbul Kuzey Klinikleri, Cilt: 8 - Sayı: 3, 249–254. https://ajindex.com/articles/551270

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Paul M, Yahav D, Fraser A, Leibovici L. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. J Antimicrob Chemother 2006;57:176–89
  2. Laoprasopwattana K, Pruekprasert P, Laosombat V, Wongchanchailert M. Clinical outcome of febrile neutropenia in children with cancer using ceftazidime and aminoglycosides. Pediatr Hematol Oncol 2007;24:595–606
  3. Pizzo PA. Management of fever in patients with cancer and treatment- induced neutropenia. N Engl J Med 1993;328:1323–32
  4. Sipsas NV, Bodey GP, Kontoyiannis DP. Perspectives for the management of febrile neutropenic patients with cancer in the 21st century. Cancer 2005;103:1103–13
  5. Lindblom A, Bhadri V, Söderhäll S, Ohrmalm L, Wong M, Norbeck O, et al. Respiratory viruses, a common microbiological finding in neutropenic children with fever. J Clin Virol 2010;47:234–7
  6. Täger F M, Zolezzi R P, Folatre B I, Navarrete C M, Rojas P J. Respiratory virus infections in children with acute lymphoblastic leukemia and febrile neutropenia: a prospective study. [Article in Spanish]. Rev Chilena Infectol 2006;23:118–23
  7. Kebudi R, Devecioğlu Ö, Gürler N. Pediatric febrile neuropathy guide: definitions and diagnostic methods. Flora 2004;2:73–105
  8. Robinson JL, Lee BE, Kothapalli S, Craig WR, Fox JD. Use of throat swab or saliva specimens for detection of respiratory viruses in children. Clin Infect Dis 2008;46:e61–4
  9. Chemaly RF, Shah DP, Boeckh MJ. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin Infect Dis 2014;59 Suppl 5:S344–51
  10. Dotan A, Ben-Shimol S, Fruchtman Y, Avni-Shemer Y, Kapelushnik J, Ben-Harush M, et al. Influenza A/H1N1 in pediatric oncology patients. J Pediatr Hematol Oncol 2014;36:e271–4
  11. Lv H, Ning B. Pathogenesis of bloodstream infection in children with blood cancer. Exp Ther Med 2013;5:201–4
  12. Paulus SC, van Saene HK, Hemsworth S, Hughes J, Ng A, Pizer BL. A prospective study of septicaemia on a paediatric oncology unit: a threeyear experience at The Royal Liverpool Children’s Hospital, Alder Hey, UK. Eur J Cancer 2005;41:2132–40
  13. Torres JP, Labraña Y, Ibañez C, Kasaneva P, Farfán MJ, De la Maza V, et al. Frequency and clinical outcome of respiratory viral infections and mixed viral-bacterial infections in children with cancer, fever and neutropenia. Pediatr Infect Dis J 2012;31:889–93
  14. Suryadevara M, Tabarani CM, B